Skip to content

Management Of Asthi Dhatu Kshaya Vikara (Osteoporosis)

Pharmaco-therapeutic study of â??Vanadrakshadi yogâ?? (Kalpita yog) in the management of â??Asthi dhatu kshay vikaraâ?? w.s.r. to Osteoporosis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030574
Enrollment
40
Registered
2021-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M810- Age-related osteoporosis without current pathological fracture

Interventions

Intervention1: Vanadrakshadi yog: 20 patients will be given Vandrakshadi yog (kalpita) capsules in dose of 500mg orally twice daily for 84 days Control Intervention1: asthishrinkhla: 20 patients will

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Well diagnosed and confirm patient of asthi dhatu kshaya vikara (Osteoporosis) Patients age above 35 years to 65 years Osteopenic / osteoporotic patients of either sex whoâ??s BMD (t score) is equal to or less than -1.8 Patient who give written consent of agreement to voluntarily participate in the clinical study.

Exclusion criteria

Exclusion criteria: Patient suffering from any veneral disease and diabetes Patient suffering from osteoporosis due to genetical and inherited disorders. Juvenile osteoporosis. Pregnant ladies and severely anemic. Osteoporosis due to hypogonadism. In the patient suffering from Hepatitis, AIDS, Malignancies, Tuberculosis, Cardiac disorders. Osteoporosis in the patient suffering from mental and acute infectious disorders. All the patients who had known allergy or contraindication to any of the drug used in this study.

Design outcomes

Primary

MeasureTime frame
Improvement in subjective and objective parametersTimepoint: 84 days

Secondary

MeasureTime frame
To compare the efficacy of treatments in both groupsTimepoint: 84 days

Countries

India

Contacts

Public ContactDr Ashok Kumar Mittal

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University College Jodhpur

chandan_singh4@yahoo.com9950156020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026